Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer
World Journal of Surgical Oncology (2017) - Comment
pubmed: 28222734  doi: 10.1186/s12957-017-1117-4  issn: 1477-7819 

Malte Krönig, Christian Haverkamp, Antonia Schulte, Laura Heinicke, Kathrin Schaal, Vanessa Drendel, Martin Werner, Ulrich Wetterauer, Wolfgang Schultze-Seemann, Cordula Annette Jilg